Farah M. Brasfield, MD, is a medical oncologist at Southern California Permanente Medical Group. She organized a regional and national team to further advance personalized medicine in oncology that utilizes genomic testing.
Dr. Brasfield is a National Cancer Institute (NCI) investigator in health care delivery systems and a sub-investigator for clinical trials in the NCI Community Oncology Research Program. She is well published and has been a frequent presenter at national and international meetings, including: the National Academy of Sciences, Engineering, and Medicine, European national society conferences, San Antonio Breast Cancer Symposium, the Leukemia & Lymphoma Society, Southwest chapter, and the Kaiser Permanente National Oncology Symposia.
Dr. Brasfield has been developing health care delivery systems that emphasize comprehensive care for cancer patients, addressing their needs from screening through survivorship in an equitable, efficient, and coordinated way. She received the James A. Vohs award for her contributions to reducing colorectal cancer mortality. Her work in cancer care equity and lowering cancer mortality is widely implemented and well documented in published research.
Dr. Brasfield earned her bachelor’s degree in biochemistry and biophysics from the University of Houston. She spent 4 years at MD Anderson Cancer Center performing cancer research and completed her medical degree at Texas A&M College of Medicine. Her internship and residency in internal medicine were followed by a fellowship in hematology/oncology at the University of Arizona under the direction of renowned hematologist/oncologist Dr. Sydney Salmon. She joined Kaiser Permanente in 1988.